Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences [Yahoo! Finance]
Madrigal Pharmaceuticals, Inc. (MDGL)
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am
Check Earnings Report
US:NASDAQ Investor Relations:
madrigalpharma.com
Company Research
Source: Yahoo! Finance
announced that the company will participate in fireside chats at three upcoming investor conferences: Jefferies Global Healthcare Conference in London Thursday, Nov. 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET) The presentation will be webcast live and may be accessed here 8th Annual Evercore Healthcare Conference Tuesday, Dec. 2, 2025 at 4:15 P.M. ET The presentation will be webcast live and may be accessed here Piper Sandler 37 th Annual Healthcare Conference Wednesday, Dec. 3, 2025 at 1:30 P.M. ET The presentation will be webcast live and may be accessed here The fireside chats will be webcast live and can be accessed by visiting Madrigal's Investor Relations Events page About Madrigal Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal's medication, Rezdiffra (resmetirom), is a once
Show less
Read more
Impact Snapshot
Event Time:
MDGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDGL alerts
High impacting Madrigal Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
MDGL
News
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Madrigal Pharmaceuticals (MDGL) Surged Following the Strong Launch and Execution of New Drug [Yahoo! Finance]Yahoo! Finance
- Madrigal Pharmaceuticals (NASDAQ:MDGL) had its price target raised by analysts at HC Wainwright from $568.00 to $620.00. They now have a "buy" rating on the stock.MarketBeat
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Madrigal Pharmaceuticals (NASDAQ:MDGL) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $600.00 to $650.00. They now have an "outperform" rating on the stock.MarketBeat